Among the 28 patients with an FGFR2-positive tumor, the survival rate of the patients who were positive for FGFR3IIIc (n = 4) was significantly poorer than that of FGFR2IIIc-negative patients (n = 24) (p = 0.003, log-rank; Fig. 3C). The gene discussed is FGFR2; the disease is neoplasm.